Coronavirus Big Update! After India, China, new COVID variant spreads in US, international travelers will now have to…, health officials to…
New Delhi: In a concerning development, India and other countries are witnessing a major spike in coronavirus cases. Reports of new confirmed COVID cases are emerging from countries including Singapore, Hong Kong, and India. A new COVID-19 variant has also been confirmed in the United States.
The Centers for Disease Control and Prevention (CDC) have detected several cases of a new COVID-19 variant called NB.1.8.1, which is being linked to a major outbreak of the virus in China. Cases related to the NB.1.8.1 variant have been found among international travelers arriving at airports in California, Washington State, Virginia, and the New York City area, according to the reports.
It is important to note that the NB.1.8.1 variant has emerged from the Omicron subvariant JN.1 — meaning it is a further mutation of JN.1. After spreading rapidly in parts of Asia, including India, this variant is now beginning to spread in the United States as well.
Currently, health officials are closely monitoring its transmission. Let’s take a look at how dangerous this variant is and what symptoms you might experience.
Here are some of the key details:
- The NB.1.8.1 variant is being detected from various parts of the country.
- The NB.1.8.1 variant was first identified in China.
- Due to this variant, a significant rise in COVID-19 cases was recorded there.
- According to the WHO, in some countries where NB.1.8.1 is widespread, despite an increase in COVID-19 cases and hospitalizations
- Current data does not indicate that this variant causes more severe illness compared to other variants.
What are the symptoms of the NB.1.8.1 variant?
Talking about the symptoms of the NB.1.8.1 variant, they are quite similar to those of the previous Omicron variants. These symptoms include:
- Sore throat
- Fatigue
- Mild cough
- Fever
- Muscle pain
- Nasal congestion
In addition to these, other symptoms may include headache, nausea, loss of appetite, and gastrointestinal issues.
News